DOLBY LABORATORIES INC-CL A
DLBNYSE🏆 #1200 by market capEarnings Nov 17US Equity
$60.95▼ $0.41 (−0.67%)
Live1h▲ 0.1%
24h▼ 0.7%
7d▼ 0.6%
14d▲ 15.9%
30d▲ 23.5%
1y▼ 15.8%
🏦Market Cap
$5.80B
Small Cap
📈Revenue Growth (YoY)
+5.9%
Slowing
📊Gross Margin
87.6%
High
💵FCF Margin
25.4%
Strong
⚖️P/S Ratio
4.3x
Fair
Otter Score
60
Fair
📊
Analyst Ratings
Price
$60.95
Total
17
Raised
3
Lowered
3
Avg PT
$90.33
H / L
$112 / $74
| Institution | Action | Rating | Date |
|---|---|---|---|
Rosenblatt | Reiterated | Buy | 2026-07-31 |
Barrington Research | Reiterated | Outperform | 2026-06-15 |
Tigress Financial | Reiterated | Buy | 2025-08-15 |
B. Riley FBR | Reiterated | Neutral | 2021-01-29 |
B. Riley Securities | Reiterated | Neutral | 2021-01-29 |
JP Morgan | Reiterated | Overweight | 2020-05-05 |
B. Riley | Upgraded | Neutral → Buy | 2020-03-24 |
RF Lafferty | Reiterated | Buy | 2018-10-22 |
Dougherty | Upgraded | Neutral → Buy | 2016-01-28 |
Dougherty & Co. | Upgraded | Neutral → Buy | 2016-01-28 |
S&P Capital IQ | Downgraded | Hold → Sell | 2014-01-23 |
Avondale Partners | Downgraded | Market Outperform → Market Perform | 2013-06-11 |
Goldman Sachs | Reiterated | Sell | 2012-12-19 |
JMP Securities | Downgraded | Market Perform → Market Underperform | 2012-11-05 |
PiperJaffray | Reiterated | Neutral | 2012-09-27 |
Piper Sandler | Reiterated | Neutral | 2012-09-27 |
Canaccord Genuity | Reiterated | Hold | 2012-05-08 |
One row per institution, most recent rating